← Eichor
Study identifier: NCT05402072 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip

Condition: Hip Arthroscopy · Articular Cartilage Defect · Microfractures  ·  Sponsor: McMaster University

PhasePhase 1
Planned participants40
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

This is a pilot multi-centre RCT of 40 patients (ages 18-55 years, inclusive) undergoing primary hip arthroscopy with a focal articular cartilage defect of the acetabulum to compare the effect of using autologous matrix-induced chondrogenesis (AMIC) in comparison to microfracture on hip function, health-related quality of life, hip pain, cartilage regeneration, health utility, and any adverse events at 2 years. Follow-up will occur at 6 weeks, 6 months, 12 months, 18 months, and 24 months post-surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Nicole Simunovic, MSc  ·  2892373224  ·  simunon@mcmaster.ca

Always discuss trial participation with your own doctor first.

Locations (1)

McMaster UniversityHamilton, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05402072